2 Hrs
Source:
المشهد
WHO approves Ebola tests
The World Health Organization has approved the inclusion of two new vaccines targeting Bundibugyo virus, a type of Ebola, in ongoing clinical trials in Africa. The vaccines are ChAdOx1 BDBV, developed by the University of Oxford and India’s Serum Institute, and Moderna’s mRNA-1469. The trials will join testing of the Ervebo vaccine, which began last month but is not approved for use against Bundibugyo. The outbreak has claimed more than 5,300 lives, with 10,444 cases recorded and a fatality rate exceeding 50%; most cases are concentrated in the Democratic Republic of the Congo.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)